skip to content
  1. Home
  2. >
  3. Investment Q&A
You can view 3 more answers this month. Sign up for a free trial for unlimited access.

Investment Q&A

Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.

Q: Can you tell me when the shares come off restriction? Iknow it is Sept. but what day? Also, is there a reasonable limit on how many options the executives of a company should award themselves and the strike price? Thanks.
Read Answer Asked by wendy on August 28, 2015
Q: CPH continues to get punished, down even on big market up days. I'm tempted to take a (big) tax loss but would value your opinion on whether to hold on for a future recovery.
Read Answer Asked by richard on August 28, 2015
Q: Way down over last little while: good dividend, high ROE, ROI and trades at PE of 6, drug in long-term trial & if successful would mean a huge incr. in scripts, sold off some OTC products to another company. Comments please as I have been watching this one for a couple of years. I own J & J in my USD portfolio already & was thinking of adding this one?
Read Answer Asked by James on August 27, 2015
Q: For high risk, what is your view on Profound Medical? It has fallen hard with other small cap. Goodman from Knight is involved financially and at the board level. Other backers include the government. I'm not in a rush with this one and under $1 it looks interesting to me.
Read Answer Asked by James on August 27, 2015
Q: Hi Peter and Staff
The value of your service keeps shining through. At least if you sour on a stock we hear about it and if you soured enough on one in your portfolio you would drop it and we would hear about it. Jason Donville is a smart man but having added one of his Top Picks from October( Cipher) ,November (Direct Cash) and December (Biosyvent) and hearing on subsequent shows he dumped Cipher and Direct Cash since, it puts a pale note on following BNN Top Picks.....is RX a sell or hold at this time, I am under water on all 3 large.
Thanks for all you do
Read Answer Asked by Dennis on August 27, 2015
Q: Hi 5i team,

At this current time would you side with PLI or NHC as a buy? I currently have CRH, PHM, PLI and CXR all around half positions. I was thinking about selling PLI and increasing my positions in CRH and CXR as they seem to have better stock momentum.

Look forward to hearing your thoughts.

Thanks as always,

Jon
Read Answer Asked by Jonathan on August 26, 2015
Q: Hello team, What's your opinion on GUD? (has hold pretty well). I was looking at a big gap @ ~ 6.15....do you think it would get fill (if you believe in gaps always getting filled)? Do you think this correction is over?
Thank you!
Read Answer Asked by Silvia on August 25, 2015
Q: My understanding is that the courts recently ruled in favour of ENL against Allergan and upheld ENL's patents. I have equity in both companies. What I don't understand is why ENL is down more than 12.5% today and Allergan down only 2.5%. Is ENL a stock worth considering buying more of?
Read Answer Asked by Neil on August 25, 2015
Q: In response to a recent inquiry you indicated Casey Hoyt, one of two new principals at PHM, owns 1.5% of the shares. Canadian Insider shows both he and Michael Moore own 19 million shares each and Max Hoyt owns 4.7 million. Collectively, that totals just under fifteen percent. In addition, according to Bruce Campbell during his Wednesday BNN appearance, they paid $1.46 per share. If these numbers are correct, that certainly provides a huge incentive for the new guys.
Has PHM commenced their share buyback and would their listing application for the TSX be in jeopardy due to price erosion?
Thanks.
Read Answer Asked by Steven on August 21, 2015
Q: I own some CRH and would like your opinion on its current state.
It seems to be dropping a bit more than most. Any fundamental news or are investors just spooked for now? Would you consider it a good hold?
Read Answer Asked by Stephen on August 21, 2015
Q: Hi, sorry for adding to the barrage of questions about PHM. But I notice the "forward P/E" ratio according to globe investor is now 5.9. This is very low, but do you have the current number? I guess I'm wondering what type of growth rate is built into this forward P/E number? Or another way to ask: if growth does slow or even stopped and they had to rely on current deals already in place, without buying more companies (with the assumption that they can't use their stock for acquisitions since it's now so low), where would Earning shake out at? Can they be profitable just integrating what they have, or do they need to issue stock and grow aggressively for them to be sustainable? If they can just slow and prosper, and then use earnings to grow later, maybe they are entering "value" territory at this price? But if they need to grow aggressively with stock, they might be in bigger trouble than the retail crowd recognizes?
Read Answer Asked by Kel on August 21, 2015
Q: I am curious about the effect of shares coming off hold after a financing where the share price is now substantially underwater. Are investors who also owned the stock previously likely to sell those shares and take a tax loss as they will still have shares from the financing? While there are obviously other issues, could this be part of the reason for the current weak market for PHM shares? What is likely to happen when the 24,000,000 shares of PHM sold @ $1.50 come off hold in early September?
Any insight you can provide on this concept in general and PHM in particular would be greatly appreciated!!
Rob
Read Answer Asked by Rob on August 21, 2015
Q: At what point do you think we could back the truck up on PHM. I understand that the fundamentals have not really changed and they are progressing forward with their ambitious growth plans. The terrible backdrop of the current market may provide a great buying opportunity?
Read Answer Asked by Bradley on August 21, 2015
Q: When the principals at phm caused the sudden downdraft there seemed to be a similar downturn in other pharma stocks in a similar market space. I tend to assume that this will not change until PHM reports earnings on a similar pace as last quarter and/or the market figures out that the new CEO has been highly successful in the past and is likely to be a good one here. 3 specific questions. 1. Do you agree with my above general assessment. 2. Does the new CEO hold an interest in the company/is some compensation in stock? 3) when does phm report earnings
?

Bryon in Elmira.
Read Answer Asked by Bryon on August 20, 2015
Q: Hello Peter
With the fiasco at phm .Would you ever recommend a stock in the future that was run by Michael Dalsin and Roger Greene.Even if fundamentals of the stock was good.
Read Answer Asked by glenn on August 20, 2015
Q: CRHJ just announced that they filed for a NASDAQ listing. What are your thoughts on this?
Read Answer Asked by Carla on August 19, 2015
Q: Hi Peter & Ryan, I'm looking for some suggestions on a solid pick to add in the healthcare sector. I currently hold PHM, GUD & PLI... Something paying a dividend would be great. Also I don't mind if it's a Canadian or US company. I was thinking of Johnson & Johnson, but would love to hear your thoughts. Many thanks. Mario
Read Answer Asked by Mario on August 18, 2015
Q: CPH continues to get punished. I hold a small position. With a forward PE of over 40, it seems CPH is overvalued even at $9.

Read Answer Asked by Albert on August 18, 2015
Looking for more? Sign up for a FREE 14 day trial! No credit card required

We invite you to sign up for a 14 day free trial of 5i Research!
Experience all the benefits and tools we have to offer; stock research, model portfolios, Q&A with our experts, and so much more. Join a community of like-minded investors today!